Mariner, LLC Cybin Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.65 $440 - $753	-1,159 Reduced 7.83%	13,650 $5,000
Q3 2023 Nov 13, 2023	SELL	$0.29 - $0.63 $1,874 - $4,071	-6,463 Reduced 30.38%	14,809 $7,000
Q1 2023 May 12, 2023	SELL	$0.3 - $0.56 $276 - $515	-921 Reduced 4.15%	21,272 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.48 - $1.11 $10,652 - $24,634	22,193 New	22,193 $11,000

185K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $2.07B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.